Abstract
Clopidogrel resistance is associated with increased periprocedural neurologic events after carotid stenting. Ticagrelor offers an improved resistance profile, but the bleeding risk of this medication has not been assessed with transfemoral carotid artery stenting (tfCAS) or transcarotid artery revascularization (TCAR). Therefore, we examined the safety and efficacy of preoperative DAPT with aspirin (ASA)/ticagrelor vs ASA/clopidogrel in patients undergoing tfCAS or TCAR.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call